19th Conference of the International Society of Geriatric Oncology

www.siogconference.org

 

Hematologic Oncology
11:32

19th Conference of the International Society of Geriatric Oncology

Polypharmacy or Mobility Assessment in Patients With Haematological Malignancies: Polypharmacy Is Highly Prevalent and Prognostic, Impaired Mobility Is Prognostic, Medications May Impact Mobility

FEATURING Tanya Wildes
  • January 17, 2020
03:59

19th Conference of the International Society of Geriatric Oncology

75 y/o Female with AML: Geriatric Assessment and Management of Lower-Intensity Therapies and Intensive Therapies

FEATURING Melissa Loh
  • 13 views
  • January 2, 2020
15:58

19th Conference of the International Society of Geriatric Oncology

AML in Older Adults: Should Intensive Therapy be Considered?

FEATURING Heidi D. Klepin
  • 56 views
  • December 31, 2019
11:27

19th Conference of the International Society of Geriatric Oncology

AML at Advanced Age: Non-Intensive Therapy with HMA (Azacitinide) May Be a Valid Option

FEATURING Reinhard Stauder
  • 22 views
  • December 31, 2019
03:16

19th Conference of the International Society of Geriatric Oncology

80 y/o Female with Limited Stage DLBCL: The Role of Chemo and Radiation Therapy

FEATURING Konstantinos Christofyllakis
  • 10 views
  • January 2, 2020
10:41

19th Conference of the International Society of Geriatric Oncology

Non-Hodgkin Lymphoma in Older Patients: Need to Identify Fit Patients w/ Aggressive Disease to Receive Full Standard Dose at 1st Line (R-CHOP / R-miniCHOP)

FEATURING Raul Cordoba
  • 41 views
  • December 31, 2019
07:34

19th Conference of the International Society of Geriatric Oncology

The Role of Radiotherapy in Older Adults with DLBCL: R-CHOPx 3/4 +ISRT May Be Good Option for Pre-Frail or Intolerant for 6 Cycles of R-CHOP

FEATURING Noam Vanderwalde
  • 12 views
  • January 2, 2020